Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice

被引:51
作者
Rothe, H [1 ]
Hibino, T [1 ]
Itoh, Y [1 ]
Kolb, H [1 ]
Martin, S [1 ]
机构
[1] UNIV DUSSELDORF,DIABET RES INST,D-40225 DUSSELDORF,GERMANY
关键词
IGIF; NOD mice; insulitis; Th1/Th2; balance;
D O I
10.1006/jaut.1997.0135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report that the onset of Th1 insulitis is preceded by a rise of interferon-gamma inducing factor (IGIF) mRNA expression in the spleen. This systemic shift towards Th1 reactivities was underlined by a close correlation of IGIF and IL-12p40 mRNA levels in the spleen, as determined by semi-quantitative RT-PCR. Cyclophosphamide-induced IGIF expression was also observed in MHC congenic NOR mice, but not in MHC class II-incompatible NON mice. The systemic rise of IGIF was followed by the development of destructive Th1-assotiated intra-insulitis. Interestingly, immunohistochemistry showed IL-4-positive cells evenly dispersed throughout the infiltrate, while IFN-gamma-positive cells were restricted to the vicinity of beta-cells. We conclude that cyclophosphamide induces a systemic shift in antigen presenting cells towards favouring Th1 responses, in an MHC dependent manner. Despite this general bias in immune reactivity, activation of Th1. cells in insulitis occurs only close to beta-cells, indicating a crucial role of antigen presentation by beta-cells or in their immediate vicinity. (C) 1997 Academic Press Limited.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 20 条
[1]   PREVENTION OF DIABETES IN THE NOD MOUSE - IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN HUMAN-DISEASE [J].
BOWMAN, MA ;
LEITER, EH ;
ATKINSON, MA .
IMMUNOLOGY TODAY, 1994, 15 (03) :115-120
[2]   T-HELPER CELL SUBSETS IN INSULIN-DEPENDENT DIABETES [J].
KATZ, JD ;
BENOIST, C ;
MATHIS, D .
SCIENCE, 1995, 268 (5214) :1185-1188
[3]   Cytokine gene expression in the BE rat pancreas: Natural course and impact of bacterial vaccines [J].
Kolb, H ;
WorzPagenstert, U ;
Kleemann, R ;
Rothe, H ;
Rowsell, P ;
Scott, FW .
DIABETOLOGIA, 1996, 39 (12) :1448-1454
[4]  
McInerney MF, 1996, J IMMUNOL, V157, P3716
[5]   MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CONTROL OF CD4 T-CELL SUBSET ACTIVATION .2. A SINGLE PEPTIDE INDUCES EITHER HUMORAL OR CELL-MEDIATED RESPONSES IN MICE OF DISTINCT MHC GENOTYPE [J].
MURRAY, JS ;
PFEIFFER, C ;
MADRI, J ;
BOTTOMLY, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (02) :559-565
[6]   CLONING OF A NEW CYTOKINE THAT INDUCES IFN-GAMMA PRODUCTION BY T-CELLS [J].
OKAMURA, H ;
TSUTSUI, H ;
KOMATSU, T ;
YUTSUDO, M ;
HAKURA, A ;
TANIMOTO, T ;
TORIGOE, K ;
OKURA, T ;
NUKADA, Y ;
HATTORI, K ;
AKITA, K ;
NAMBA, M ;
TANABE, F ;
KONISHI, K ;
FUKUDA, S ;
KURIMOTO, M .
NATURE, 1995, 378 (6552) :88-91
[7]  
RABINOVITCH A, 1994, DIABETOLOGIA, V37, P833, DOI 10.1007/BF00404341
[8]  
RADONS J, 1997, DIABETES, V45, P379
[9]   TH1 AND TH2 T-CELL SUBSETS ARE DIFFERENTIALLY ACTIVATED BY MACROPHAGES AND B-CELLS IN MURINE LEISHMANIASIS [J].
ROSSIBERGMANN, B ;
MULLER, I ;
GODINHO, EB .
INFECTION AND IMMUNITY, 1993, 61 (05) :2266-2269
[10]  
Rothe H, 1996, DIABETOLOGIA, V39, P119